SciELO - Scientific Electronic Library Online

vol.33 número2Storage lipids and proteins of Euterpe edulis seedsA six-rhabdomere, open rhabdom arrangement in the eye of the chrysanthemum beetle Phytoecia rufiventris: some ecophysiological predictions based on eye anatomy índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados




  • No hay articulos citadosCitado por SciELO

Links relacionados



versión impresa ISSN 0327-9545


LEE, Chang Seok et al. Simvastatin acts as an inhibitor of interferon gamma-induced cycloxygenase-2 expression in human THP-1 cells, but not in murine RAW264.7 cells. Biocell [online]. 2009, vol.33, n.2, pp.107-114. ISSN 0327-9545.

Cyclooxygenase-2 (COX-2) is a key inflammatory response molecule, and associated with many immune functions of monocytes/macrophages. Particularly, interferon gamma (IFNg)-induced COX-2 expression appears in inflammatory conditions such as viral infection and autoimmune diseases. Recently, statins have been reported to show variable effects on COX-2 expression, and on their cell and species type dependences. Based on the above description, we compared the effect of simvastatin on IFNg-induced COX-2 expression in human monocytes versus murine macrophages. In a result, we found that simvastatin suppresses IFNg-induced COX-2 expression in human THP-1 monocytes, but rather, potentiates IFNg-induced COX-2 expression in murine RAW264.7 macrophages. However, signal transducer and activator of transcription 1/3 (STAT1/3), known as a transcription factor on COX-2 expression, is inactivated by simvastatin in both cells. Our findings showed that simvastatin is likely to suppress IFNg-induced COX-2 expression by inhibiting STAT1/3 activation in human THP-1 cells, but not in murine RAW264.7 cells. Thus, we concluded that IFNg-induced COX-2 expression is differently regulated by simvastatin depending on species specific mechanism.

Palabras clave : Monocyte; Macrophage; INFg; STAT1/3; SOCS1/3.

        · texto en Inglés     · Inglés ( pdf )


Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons